XML 98 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($)
$ in Millions
Total
Previously Reported
Common Stock
Common Stock
Previously Reported
Treasury Stock
Treasury Stock
Previously Reported
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Other Comprehensive (Loss)
Accumulated Other Comprehensive (Loss)
Previously Reported
Beginning Balance (in shares) at Dec. 31, 2018     123,353,656   12,811,755              
Beginning Balance at Dec. 31, 2018 $ 6.3   $ 1.2   $ (62.6)   $ 361.0   $ (289.8)   $ (3.5)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 4.5           4.5          
Issuance of common stock related to share-based compensation plans (in shares)     2,613                  
Exercise of vested stock options (in shares)     145,235                  
Exercise of vested stock options 0.4           0.4          
Dividends paid/accrued (5.0)           (5.0)          
Acquisition of treasury stock related to share-based compensation plans (in shares)         (342,998)              
Acquisition of treasury stock related to share-based compensation plans (3.3)       $ (3.3)              
Forfeitures (in shares)         (1,208)              
Net change on derivatives designated as cash flow hedges, net of tax 0.2                   0.2  
Foreign currency translation adjustments 0.5                   0.5  
Net income (loss) 0.2               0.2      
Ending Balance (in shares) at Mar. 31, 2019     123,501,504   13,155,961              
Ending Balance at Mar. 31, 2019 3.8   $ 1.2   $ (65.9)   360.9   (289.6)   (2.8)  
Beginning Balance (in shares) at Dec. 31, 2019       127,807,546   13,786,266            
Beginning Balance at Dec. 31, 2019 18.1 $ 18.1   $ 1.3   $ (73.6)   $ 372.7   $ (277.8)   $ (4.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense $ 4.8           4.8          
Issuance of common stock related to share-based compensation plans (in shares)     1,720                  
Exercise of vested stock options (in shares) 553,520   553,520                  
Exercise of vested stock options $ 3.1           3.1          
Dividends paid/accrued (5.4)           (5.4)          
Acquisition of treasury stock related to share-based compensation plans (in shares)         (545)              
Acquisition of treasury stock related to share-based compensation plans 0.0       $ 0.0              
Net change on derivatives designated as cash flow hedges, net of tax (4.4)                   (4.4)  
Foreign currency translation adjustments (2.1)                   (2.1)  
Net income (loss) 18.2               18.2      
Ending Balance (in shares) at Mar. 31, 2020     128,362,786   13,786,811              
Ending Balance at Mar. 31, 2020 $ 31.5   $ 1.3   $ (73.6)   $ 375.2   $ (260.4)   $ (11.0)